Denali 制药 DNLI
$20.07 +$0.35 (+1.77%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.16 +0.45%
开盘$19.97
昨收$19.72
当日区间$19.78 – $20.36
成交量1.59M
市值$3.22B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$3.60M
营业利润-$130.54M+3.3% YoY
净利润-$127.55M-2.8% YoY
摊薄每股收益-$0.68+5.6% YoY
自由现金流-$126.61M-59.1% YoY
经营现金流-$97.00M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率97.4%
营业利润率-15,058.2%
净利率-14,191.2%
净资产收益率-54.9%
资产收益率-44.0%
投入资本回报率-55.9%
流动比率8.37
负债/资产比率27.9%
现金及投资$710.47M
总负债$22.03M
净现金（净负债）$688.45M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $3.60M | – | $0.00 | – | – |
| 营业总收入 | $3.60M | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业成本 | $93,000.00 | – | – | – | – |
| 毛利润 | $3.51M | – | – | – | – |
| 营业费用 | $134.05M | $137.36M | $555.34M | $137.37M | $137.43M |
| 销售及管理费用 | $36.28M | $33.51M | $136.56M | $39.46M | $35.48M |
| -管理费用 | $36.28M | $33.51M | $136.56M | $39.46M | $35.48M |
| 研发费用 | $97.02M | $103.85M | $418.78M | $97.91M | $101.95M |
| 折旧、摊销与折耗 | $750,000.00 | – | – | – | – |
| -折旧与摊销 | $750,000.00 | – | – | – | – |
| 营业利润 | -$130.54M | -$137.36M | -$555.34M | -$137.37M | -$137.43M |
| 非经营性利息净收入（支出） | $2.99M | $8.91M | $42.90M | $8.92M | $10.53M |
| 非经营性利息收入 | $2.99M | $8.91M | $42.90M | $8.92M | $10.53M |
| 税前利润 | -$127.55M | -$128.45M | -$512.44M | -$128.45M | -$126.90M |
| 净利润 | -$127.55M | -$128.45M | -$512.54M | -$128.55M | -$126.90M |
| 持续经营利润 | -$127.55M | -$128.45M | -$512.54M | -$128.55M | -$126.90M |
| 归属母公司净利润 | -$127.55M | -$128.45M | -$512.54M | -$128.55M | -$126.90M |
| 归属普通股股东净利润 | -$127.55M | -$128.45M | -$512.54M | -$128.55M | -$126.90M |
| 基本每股收益 | -$0.68 | -$0.69 | -$2.97 | -$0.73 | -$0.74 |
| 摊薄每股收益 | -$0.68 | -$0.69 | -$2.97 | -$0.73 | -$0.74 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -业务出售收益 | – | – | $0.00 | $0.00 | $0.00 |
| 税费 | – | – | $102,000.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.16B | $1.27B | $1.14B | $1.14B | $1.06B |
| 流动资产合计 | $753.93M | $1.02B | $900.66M | $900.66M | $882.60M |
| 现金及现金等价物与短期投资 | $710.47M | $987.68M | $867.88M | $867.88M | $848.20M |
| -现金及现金等价物 | $201.53M | $387.63M | $205.33M | $205.33M | $90.96M |
| -短期投资 | $508.94M | $600.06M | $662.55M | $662.55M | $757.24M |
| 应收款 | $3.93M | – | $2.18M | $2.18M | – |
| -应收账款 | $3.93M | – | $2.18M | $2.18M | – |
| 存货 | $4.14M | – | – | – | – |
| 其他流动资产 | $35.39M | $35.07M | – | – | $34.39M |
| 非流动资产合计 | $404.03M | $243.27M | $244.20M | $244.20M | $173.02M |
| 固定资产净值 | $113.42M | $117.27M | $119.94M | $119.94M | $123.21M |
| -固定资产原值 | $113.42M | $117.27M | $182.83M | $182.83M | $123.21M |
| 投资及预付款 | $229.53M | $63.79M | $98.32M | $98.32M | $24.70M |
| 商誉及其他无形资产 | $35.25M | $36.00M | – | – | – |
| 其他非流动资产 | $25.83M | $26.22M | $25.94M | $25.94M | $25.11M |
| 负债合计 | $322.78M | $339.93M | $131.09M | $131.09M | $129.42M |
| 流动负债合计 | $90.08M | $110.16M | $98.35M | $98.35M | $90.15M |
| 应付款 | $11.81M | $40.38M | $3.33M | $3.33M | $6.75M |
| -应付账款 | $11.81M | $40.38M | $3.33M | $3.33M | $6.75M |
| 一年内应计费用 | $34.70M | $35.58M | $32.20M | $32.20M | $33.30M |
| 短期债务及融资租赁负债 | $10.18M | $9.86M | $9.55M | $9.55M | $9.16M |
| -一年内到期融资租赁负债 | $10.18M | $9.86M | $9.55M | $9.55M | $9.16M |
| 一年内递延负债 | $19.98M | $15.12M | $21.10M | $21.10M | $22.58M |
| 非流动负债合计 | $232.69M | $229.77M | $32.74M | $32.74M | $39.28M |
| 长期债务及融资租赁负债 | $22.03M | $24.68M | $27.21M | $27.21M | $35.24M |
| -长期融资租赁负债 | $22.03M | $24.68M | $27.21M | $27.21M | $35.24M |
| 一年以上递延负债 | $205.19M | $199.58M | – | – | $4.04M |
| 其他非流动负债 | $5.48M | $5.51M | $5.53M | $5.53M | – |
| 股东权益合计 | $835.18M | $926.10M | $1.01B | $1.01B | $926.20M |
| 股东权益 | $835.18M | $926.10M | $1.01B | $1.01B | $926.20M |
| 股本 | $1.92M | $1.91M | $1.89M | $1.89M | $1.79M |
| -普通股 | $1.92M | $1.91M | $1.89M | $1.89M | $1.79M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $3.14B | $3.10B | $3.06B | $3.06B | $2.85B |
| 留存收益 | -$2.31B | -$2.18B | -$2.05B | -$2.05B | -$1.92B |
| 不影响留存收益的损益 | -$1.97M | -$682,000.00 | $682,000.00 | $682,000.00 | $1.10M |
| 预付资产 | – | – | $30.60M | $30.60M | – |
| -累计折旧 | – | – | -$62.90M | -$62.90M | – |
| -可供出售证券 | – | – | – | – | $24.70M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$97.00M | -$131.20M | -$412.60M | -$98.54M | -$107.30M |
| 持续经营经营活动现金流净额 | -$97.00M | -$131.20M | -$412.60M | -$98.54M | -$107.30M |
| 持续经营净利润 | -$127.55M | -$128.45M | -$512.54M | -$128.55M | -$126.90M |
| 折旧、折耗与摊销 | $4.48M | $3.76M | $14.81M | $3.78M | $3.86M |
| 其他非现金项目 | $4.22M | -$850,000.00 | -$4.40M | -$1.10M | -$1.14M |
| 营运资金变动 | $382,000.00 | -$27.50M | $149,000.00 | $5.02M | -$6.22M |
| -预付资产变动 | -$322,000.00 | -$2.29M | -$540,000.00 | $1.75M | $1.36M |
| -应付账款及应计费用变动 | $3.52M | -$18.52M | -$7.06M | $9.32M | -$2.18M |
| -其他流动资产变动 | $396,000.00 | -$700,000.00 | $772,000.00 | -$533,000.00 | -$1.72M |
| -其他营运资金变动 | $4.86M | -$5.99M | $6.97M | -$5.52M | -$3.69M |
| 投资活动现金流净额 | -$104.08M | $94.46M | $255.28M | $20.77M | $57.83M |
| 持续经营投资活动现金流净额 | -$104.08M | $94.46M | $255.28M | $20.77M | $57.83M |
| 固定资产购置及出售净额 | -$805,000.00 | -$2.47M | -$9.50M | -$1.52M | $1.38M |
| 投资购置及出售净额 | -$74.47M | $96.93M | $264.78M | $22.29M | $56.45M |
| 筹资活动现金流 | $14.98M | $219.04M | $189.22M | $192.13M | -$778,000.00 |
| 持续经营筹资活动现金流净额 | $14.98M | $219.04M | $189.22M | $192.13M | -$778,000.00 |
| 债务发行及偿还净额 | -$21,000.00 | -$17,000.00 | -$8.17M | -$16,000.00 | -$1.36M |
| 股票期权行使所得 | $15.01M | $19.06M | $8.46M | $3.22M | $583,000.00 |
| 其他筹资费用净额 | $0.00 | $200.00M | -$324,000.00 | – | – |
| 期末现金余额 | $204.64M | $390.73M | $208.43M | $208.43M | $94.07M |
| 现金净变动 | -$186.10M | $182.30M | $31.90M | $114.36M | -$50.24M |
| 期初现金余额 | $390.73M | $208.43M | $176.54M | $94.07M | $144.31M |
| 自由现金流 | -$126.61M | -$133.67M | -$422.10M | -$100.06M | -$105.92M |
| -其他流动负债变动 | – | – | $0.00 | – | – |
| 普通股发行净额 | – | – | $189.25M | $189.25M | – |
暂无评论——快来第一个聊聊 DNLI。
登录后参与讨论。